Loading…
Attending this event?
Back To Schedule
Tuesday, June 21 • 9:15am - 10:15am
#210: Challenges of Translational and Early-Phase ASO Development

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-22-547-L04-P ; CME 1.00; RN 1.00

This session will discuss biomarker and/or model development considerations in ASO development.

Learning Objectives

Describe the opportunity non-linear imaging provides to track ASO distribution.

Chair

Yuri Zamostin

Speaker

Harnessing the Power of Multimodal Imaging to Explore ASO Distribution in Cells, Complex In Vitro Models, and Tissue
Steve Hood, PhD



Speakers
SH

Steve Hood

Senior Director, Imaging Networks, GlaxoSmithKline, United Kingdom
Steve Hood received a PhD in Molecular Toxicology from the University of Surrey in 1993 and joined Glaxo Group Research as an Industrial Post doc. Steve is now a senior Scientific Director in Bioimaging, responsible for external imaging collaborations in the Bioimaging Expertise Network... Read More →
avatar for Anita Nelsen

Anita Nelsen

Executive Vice President, Translational Medicine, Parexel, United States
Anita is a pharmaceutical industry leader who has applied pharmacogenetic, human and molecular genetics research in drug discovery and development. As Head of Translational Medicine, Anita leads a global team of scientists who are recognized thought leaders and influencers in early... Read More →
avatar for Yuri Zamostin

Yuri Zamostin

Executive Vice President, Translational Medicine, Parexel, United States
Anita is a pharmaceutical industry leader who has applied pharmacogenetic, human and molecular genetics research in drug discovery and development. As Head of Translational Medicine, Anita leads a global team of scientists who are recognized thought leaders and influencers in early... Read More →


Tuesday June 21, 2022 9:15am - 10:15am CDT
Room 183 B McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  06: PreClinical Dev-EarlyPhaseCR, Session